Benzinga | Nov 24, 2020 08:42AM EST

Berenberg Initiates Coverage On Cue Biopharma with Buy Rating, Announces Price Target of $30

Berenberg initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Buy rating and announces Price Target of $30.